Myocardin: A Potential Drug Target for Cardiovascular Diseases

Target Name: MYOCD

NCBI ID: G93649

MYOCD

Myocardin: A Potential Drug Target for Cardiovascular Diseases

Myocardin, also known as cardiomyocyte-specific enamic acid, is a protein highly expressed in cardiomyocytes. Research shows that myocardin plays an important role in cardiovascular diseases such as myocardial ischemia and myocardial infarction. In addition, myocardin is also related to cardiomyocyte apoptosis and neuroendocrine cell function, so it is considered a potential drug target.

First, the mechanism of action of myocardin in myocardial ischemia has been extensively studied. Studies have shown that myocardin can protect cardiomyocytes from ischemia-reperfusion injury, thereby saving cardiomyocytes and improving the prognosis of patients with myocardial ischemia. In addition, myocardin can also increase the Ca2+ content in myocardial cells, thereby inhibiting the excessive contraction of myocardial cells and reducing the risk of myocardial infarction.

Secondly, the role of myocardin in the treatment of myocardial infarction has also received attention. Studies have shown that myocardin can significantly improve myocardial function and survival rate in patients with myocardial infarction, while also reducing the inflammatory response of cardiomyocytes and promoting the repair and regeneration of cardiomyocytes.

In addition to its role in cardiovascular disease, myocardin is also closely related to cardiomyocyte apoptosis. Research shows that myocardin can activate cardiomyocyte apoptosis, thereby clearing damaged cardiomyocytes and creating conditions for heart repair and regeneration. In addition, myocardin can also regulate the function of neuroendocrine cells, thereby affecting the contractile and conductive functions of the heart.

In summary, myocardin, as a protein with high expression in cardiomyocytes, has important biological significance in cardiovascular diseases. Its mechanism of action includes protecting myocardial cells from ischemia-reperfusion injury, increasing the Ca2+ content in myocardial cells, and improving the survival rate of patients with myocardial infarction. Therefore, myocardin is considered a potential drug target with broad application prospects.

Protein Name: Myocardin

Functions: Smooth muscle cells (SM) and cardiac muscle cells-specific transcriptional factor which uses the canonical single or multiple CArG boxes DNA sequence. Acts as a cofactor of serum response factor (SRF) with the potential to modulate SRF-target genes. Plays a crucial role in cardiogenesis, urinary bladder development, and differentiation of the smooth muscle cell lineage (myogenesis) (By similarity)

The "MYOCD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYOCD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets